Carolyn Sue

Carolyn Mary Sue is an Australian neurologist, scientist, professor and research director. She has been the executive director of the Kolling Institute of Medical Research since 2019 and is also Director of Neurogenetics at Royal North Shore Hospital, Director of the Centre of Excellence for Parkinson's Disease and Movement Disorders, and Director of the National Centre for Adult Stem Cell Research (Sydney Node). Sue specialises in complex neurogenetic conditions and runs tertiary referral clinics for patients with diseases such as Parkinson's, mitochondrial diseases, and other inherited movement disorders.

Education and career Sue completed a medical degree at the University of New South Wales and a PhD at the University of Sydney in 1997. She then received an NHMRC Neil Hamilton Fairley Postdoctoral Fellowship to conduct post-doctoral studies in the laboratory of Salvatore DiMauro at Columbia University in New York City.

Professor Sue holds multiple titles and was the inaugural Professor in Neurology at Royal North Shore Hospital. She is also a Founding Director of the Australian Mitochondrial Disease Foundation, President-Elect for the Movement Disorder Society of Australia and New Zealand, and co-chair of the Education Committee for the International Parkinson's Disease and Movement Disorder Society. Mitochondrial donation allows the replacement of defective mitochondria with healthy mitochondria in an unborn child, with requires the use assisted reproductive technologies to conceive a child from the genetic material of three persons. Sue's future work will likely involve preparing and supporting her patients if they choose to undergo the procedure.

Awards and recognition In 2016, Sue was awarded a Presidential Award by the International Parkinson's Disease and Movement Disorder Society. In 2019, Sue was part of the Queen's Birthday Honours List and awarded a Member of the Order of Australia for significant services to medicine. Academy elects 28 new Fellows. Carolyn Sue clinician scientist highly recognised with all the research work done. Prof. Carolyn Sue was awarded $1.2 million for work done in precision diagnosis & patients with mitochondrial disease.